Nectar Lifesciences Sells API, Formulations, and Menthol Business to Ceph Lifesciences for ₹1,290 Crore Business The deal will not alter Nectar’s existing shareholding structure.
Mohanlal Joins "Operation Toofan": Kerala's Three-Phase Anti-Drug Initiative With Central Agency Support National
US Military Plans Permanent Weapons Stockpile in Australia Beyond Chinese Missile Range International